338 related articles for article (PubMed ID: 19380575)
1. Greater transport efficiencies of the membrane fatty acid transporters FAT/CD36 and FATP4 compared with FABPpm and FATP1 and differential effects on fatty acid esterification and oxidation in rat skeletal muscle.
Nickerson JG; Alkhateeb H; Benton CR; Lally J; Nickerson J; Han XX; Wilson MH; Jain SS; Snook LA; Glatz JFC; Chabowski A; Luiken JJFP; Bonen A
J Biol Chem; 2009 Jun; 284(24):16522-16530. PubMed ID: 19380575
[TBL] [Abstract][Full Text] [Related]
2. Metabolic challenges reveal impaired fatty acid metabolism and translocation of FAT/CD36 but not FABPpm in obese Zucker rat muscle.
Han XX; Chabowski A; Tandon NN; Calles-Escandon J; Glatz JF; Luiken JJ; Bonen A
Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E566-75. PubMed ID: 17519284
[TBL] [Abstract][Full Text] [Related]
3. Additive effects of insulin and muscle contraction on fatty acid transport and fatty acid transporters, FAT/CD36, FABPpm, FATP1, 4 and 6.
Jain SS; Chabowski A; Snook LA; Schwenk RW; Glatz JF; Luiken JJ; Bonen A
FEBS Lett; 2009 Jul; 583(13):2294-300. PubMed ID: 19527715
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid binding protein facilitates sarcolemmal fatty acid transport but not mitochondrial oxidation in rat and human skeletal muscle.
Holloway GP; Lally J; Nickerson JG; Alkhateeb H; Snook LA; Heigenhauser GJ; Calles-Escandon J; Glatz JF; Luiken JJ; Spriet LL; Bonen A
J Physiol; 2007 Jul; 582(Pt 1):393-405. PubMed ID: 17478525
[TBL] [Abstract][Full Text] [Related]
5. Prolonged AMPK activation increases the expression of fatty acid transporters in cardiac myocytes and perfused hearts.
Chabowski A; Momken I; Coort SL; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Bonen A
Mol Cell Biochem; 2006 Aug; 288(1-2):201-12. PubMed ID: 16710744
[TBL] [Abstract][Full Text] [Related]
6. A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism.
Bonen A; Han XX; Habets DD; Febbraio M; Glatz JF; Luiken JJ
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1740-9. PubMed ID: 17264223
[TBL] [Abstract][Full Text] [Related]
7. HIV-protease inhibitors suppress skeletal muscle fatty acid oxidation by reducing CD36 and CPT1 fatty acid transporters.
Richmond SR; Carper MJ; Lei X; Zhang S; Yarasheski KE; Ramanadham S
Biochim Biophys Acta; 2010 May; 1801(5):559-66. PubMed ID: 20117238
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of contraction and PPAR agonists on the expression of fatty acid transporters in rat skeletal muscle.
Benton CR; Koonen DP; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Heikkila JJ; Bonen A
J Physiol; 2006 May; 573(Pt 1):199-210. PubMed ID: 16484294
[TBL] [Abstract][Full Text] [Related]
9. Co-overexpression of CD36 and FABPpm increases fatty acid transport additively, not synergistically, within muscle.
Holloway GP; Nickerson JG; Lally JSV; Petrick HL; Dennis KMJH; Jain SS; Alkhateeb H; Bonen A
Am J Physiol Cell Physiol; 2022 Mar; 322(3):C546-C553. PubMed ID: 35138177
[TBL] [Abstract][Full Text] [Related]
10. Increasing skeletal muscle fatty acid transport protein 1 (FATP1) targets fatty acids to oxidation and does not predispose mice to diet-induced insulin resistance.
Holloway GP; Chou CJ; Lally J; Stellingwerff T; Maher AC; Gavrilova O; Haluzik M; Alkhateeb H; Reitman ML; Bonen A
Diabetologia; 2011 Jun; 54(6):1457-67. PubMed ID: 21442160
[TBL] [Abstract][Full Text] [Related]
11. Skeletal muscle proteins involved in fatty acid transport influence fatty acid oxidation rates observed during exercise.
Maunder E; Rothschild JA; Fritzen AM; Jordy AB; Kiens B; Brick MJ; Leigh WB; Chang WL; Kilding AE
Pflugers Arch; 2023 Sep; 475(9):1061-1072. PubMed ID: 37464190
[TBL] [Abstract][Full Text] [Related]
12. Novel role of FATP1 in mitochondrial fatty acid oxidation in skeletal muscle cells.
Sebastián D; Guitart M; García-Martínez C; Mauvezin C; Orellana-Gavaldà JM; Serra D; Gómez-Foix AM; Hegardt FG; Asins G
J Lipid Res; 2009 Sep; 50(9):1789-99. PubMed ID: 19429947
[TBL] [Abstract][Full Text] [Related]
13. The subcellular compartmentation of fatty acid transporters is regulated differently by insulin and by AICAR.
Chabowski A; Coort SL; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Bonen A
FEBS Lett; 2005 Apr; 579(11):2428-32. PubMed ID: 15848183
[TBL] [Abstract][Full Text] [Related]
14. Evidence for concerted action of FAT/CD36 and FABPpm to increase fatty acid transport across the plasma membrane.
Chabowski A; Górski J; Luiken JJ; Glatz JF; Bonen A
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):345-53. PubMed ID: 18240411
[TBL] [Abstract][Full Text] [Related]
15. Acute endurance exercise increases plasma membrane fatty acid transport proteins in rat and human skeletal muscle.
Bradley NS; Snook LA; Jain SS; Heigenhauser GJ; Bonen A; Spriet LL
Am J Physiol Endocrinol Metab; 2012 Jan; 302(2):E183-9. PubMed ID: 22028411
[TBL] [Abstract][Full Text] [Related]
16. Different mechanisms can alter fatty acid transport when muscle contractile activity is chronically altered.
Koonen DP; Benton CR; Arumugam Y; Tandon NN; Calles-Escandon J; Glatz JF; Luiken JJ; Bonen A
Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E1042-9. PubMed ID: 15140757
[TBL] [Abstract][Full Text] [Related]
17. Chronic leptin administration decreases fatty acid uptake and fatty acid transporters in rat skeletal muscle.
Steinberg GR; Dyck DJ; Calles-Escandon J; Tandon NN; Luiken JJ; Glatz JF; Bonen A
J Biol Chem; 2002 Mar; 277(11):8854-60. PubMed ID: 11729182
[TBL] [Abstract][Full Text] [Related]
18. In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation.
Holloway GP; Benton CR; Mullen KL; Yoshida Y; Snook LA; Han XX; Glatz JF; Luiken JJ; Lally J; Dyck DJ; Bonen A
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E738-47. PubMed ID: 19141681
[TBL] [Abstract][Full Text] [Related]
19. Caffeine-stimulated fatty acid oxidation is blunted in CD36 null mice.
Lally JSV; Jain SS; Han XX; Snook LA; Glatz JFC; Luiken JJFP; McFarlan J; Holloway GP; Bonen A
Acta Physiol (Oxf); 2012 May; 205(1):71-81. PubMed ID: 22463611
[TBL] [Abstract][Full Text] [Related]
20. Tissue-specific and fatty acid transporter-specific changes in heart and soleus muscle over a 1-yr period.
Bonen A; Nickerson JG; Momken I; Chabowski A; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ
Mol Cell Biochem; 2006 Oct; 291(1-2):145-54. PubMed ID: 16718359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
